An investigation carried out by scientists from the cancer center City of Hope of California, in the United States, published in the magazine Cancer Prevention Research, has revealed that chemical compounds found in pomegranates can reduce the risk of developing a type of breast cancer associated with estrogen receptors.
Shiuan Chen, author of the research, explains that they have managed to identify ten substances present in the pomegranate that have the ability to inhibit the activity of aromatase, an enzyme that plays an important role in the development of these tumors, because it intervenes in the production of estrogen.
In previous research, it was already proven that consuming the juice of this fruit, rich in antioxidants and vitamins, helps prevent the onset of heart disease, cancer and Alzheimer's disease.
The authors of the study do not claim that the new compounds discovered replace the drugs currently available, and that they act as aromatase inhibitors because, as Dr. Chen explains, their potency is lower than that of the available drugs, so the research focuses more on the preventive possibilities than on the therapeutic efficacy.
Several scientists who have not participated in the study have highlighted that these are promising results and that it is convenient to carry out more studies that ratify the obtained data. According to Gary Stoner, of the Ohio State University, It has not yet been proven whether the necessary levels could be achieved in animals or humans because there is not a good absorption of the compounds in the blood when they are obtained through the diet.